Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10652225rdf:typepubmed:Citationlld:pubmed
pubmed-article:10652225lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10652225lifeskim:mentionsumls-concept:C0014833lld:lifeskim
pubmed-article:10652225lifeskim:mentionsumls-concept:C0025543lld:lifeskim
pubmed-article:10652225lifeskim:mentionsumls-concept:C0036734lld:lifeskim
pubmed-article:10652225lifeskim:mentionsumls-concept:C2717971lld:lifeskim
pubmed-article:10652225lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:10652225lifeskim:mentionsumls-concept:C0246551lld:lifeskim
pubmed-article:10652225pubmed:issue1lld:pubmed
pubmed-article:10652225pubmed:dateCreated2000-3-1lld:pubmed
pubmed-article:10652225pubmed:abstractTextTreatment of human uterine cervical fibroblasts with commercial lipopolysaccharide (LPS) preparations from different serotypes of Escherichia coli effectively augmented the processing of mammalian progelatinase A/promatrix metalloproteinase (proMMP)-2 to a 62-kDa form of MMP-2. When purified proMMP-2 was incubated with LPS preparations, the proenzyme was similarly processed into the 62-kDa active MMP-2 in a time- and dose-dependent manner. By contrast, progelatinase B/proMMP-9 and prostromelysin 1/proMMP-3 were not activated. A serine proteinase inhibitor, phenylmethylsulfonyl fluoride, completely interfered with this LPS-mediated activation of proMMP-2. This is novel evidence that E. coli serine proteinase is a specific activator of proMMP-2. Thus, it is very likely that E. coli infection plays a crucial role in the degradation of connective tissues via the activation of proMMP-2, and the resultant active MMP-2 participates in the dysfunction of connective tissues such as in the preterm rupture of fetal membranes.lld:pubmed
pubmed-article:10652225pubmed:languageenglld:pubmed
pubmed-article:10652225pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652225pubmed:citationSubsetIMlld:pubmed
pubmed-article:10652225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652225pubmed:statusMEDLINElld:pubmed
pubmed-article:10652225pubmed:monthFeblld:pubmed
pubmed-article:10652225pubmed:issn0006-291Xlld:pubmed
pubmed-article:10652225pubmed:authorpubmed-author:SatoTTlld:pubmed
pubmed-article:10652225pubmed:authorpubmed-author:ItoAAlld:pubmed
pubmed-article:10652225pubmed:authorpubmed-author:TakedaMMlld:pubmed
pubmed-article:10652225pubmed:authorpubmed-author:ImadaKKlld:pubmed
pubmed-article:10652225pubmed:copyrightInfoCopyright 2000 Academic Press.lld:pubmed
pubmed-article:10652225pubmed:issnTypePrintlld:pubmed
pubmed-article:10652225pubmed:day5lld:pubmed
pubmed-article:10652225pubmed:volume268lld:pubmed
pubmed-article:10652225pubmed:ownerNLMlld:pubmed
pubmed-article:10652225pubmed:authorsCompleteYlld:pubmed
pubmed-article:10652225pubmed:pagination128-32lld:pubmed
pubmed-article:10652225pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:meshHeadingpubmed-meshheading:10652225...lld:pubmed
pubmed-article:10652225pubmed:year2000lld:pubmed
pubmed-article:10652225pubmed:articleTitleActivation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase.lld:pubmed
pubmed-article:10652225pubmed:affiliationDepartment of Pharmacy, Tsukuba University Hospital, Amakubo, Tsukuba, Ibaraki, 305-8756, Japan.lld:pubmed
pubmed-article:10652225pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10652225pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652225lld:pubmed